A hard-to-treat form of breast cancer sometimes called “triple negative” is more like certain kinds of ovarian and lung cancers than like other breast cancers, and so doctors may be able to treat it with drugs known to work in tumors in these different tissues, suggests the latest report from the Cancer Genome Atlas.
Much of what genomics is teaching us about cancer is that every cancer type and even every tumor is different at the genetic and molecular level (not to mention that different parts of a tumor can have molecular changes not found throughout). But researchers are also finding that tumors from different parts of the body can be more alike than tumors found in the same organ, as was shown in Sunday’s report in Nature.
“We’re going to move farther and farther from the practice of classifying cancers by where they arise and more and more by what their molecular composition and wiring is all about.”
DeepMind’s cofounder: Generative AI is just a phase. What’s next is interactive AI.
“This is a profound moment in the history of technology,” says Mustafa Suleyman.
What to know about this autumn’s covid vaccines
New variants will pose a challenge, but early signs suggest the shots will still boost antibody responses.
Human-plus-AI solutions mitigate security threats
With the right human oversight, emerging technologies like artificial intelligence can help keep business and customer data secure
Next slide, please: A brief history of the corporate presentation
From million-dollar slide shows to Steve Jobs’s introduction of the iPhone, a bit of show business never hurt plain old business.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.